↓ Skip to main content

Allergen-specific immunotherapy

Overview of attention for article published in Allergy, Asthma & Clinical Immunology, November 2011
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • Among the highest-scoring outputs from this source (#48 of 924)
  • High Attention Score compared to outputs of the same age (97th percentile)
  • High Attention Score compared to outputs of the same age and source (95th percentile)

Mentioned by

news
4 news outlets
blogs
1 blog
twitter
7 X users

Citations

dimensions_citation
32 Dimensions

Readers on

mendeley
63 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Allergen-specific immunotherapy
Published in
Allergy, Asthma & Clinical Immunology, November 2011
DOI 10.1186/1710-1492-7-s1-s5
Pubmed ID
Authors

William Moote, Harold Kim

Abstract

Allergen-specific immunotherapy is a potentially disease-modifying therapy that is effective for the treatment of allergic rhinitis/conjunctivitis, allergic asthma and stinging insect hypersensitivity. However, despite its proven efficacy in these conditions, it is frequently underutilized in Canada. The decision to proceed with allergen-specific immunotherapy should be made on a case-by-case basis, taking into account individual patient factors such as the degree to which symptoms can be reduced by avoidance measures and pharmacological therapy, the amount and type of medication required to control symptoms, the adverse effects of pharmacological treatment, and patient preferences. Since this form of therapy carries the risk of anaphylactic reactions, it should only be prescribed by physicians who are adequately trained in the treatment of allergy. Furthermore, injections must be given under medical supervision in clinics that are equipped to manage anaphylaxis. In this article, the authors review the indications and contraindications, patient selection criteria, and the administration, safety and efficacy of allergen-specific immunotherapy.

X Demographics

X Demographics

The data shown below were collected from the profiles of 7 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 63 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United Kingdom 1 2%
Russia 1 2%
Tunisia 1 2%
Egypt 1 2%
Unknown 59 94%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 25 40%
Researcher 18 29%
Student > Master 17 27%
Student > Ph. D. Student 9 14%
Professor > Associate Professor 8 13%
Other 27 43%
Readers by discipline Count As %
Medicine and Dentistry 45 71%
Agricultural and Biological Sciences 20 32%
Biochemistry, Genetics and Molecular Biology 13 21%
Immunology and Microbiology 11 17%
Veterinary Science and Veterinary Medicine 4 6%
Other 6 10%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 40. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 14 July 2023.
All research outputs
#1,025,077
of 25,374,647 outputs
Outputs from Allergy, Asthma & Clinical Immunology
#48
of 924 outputs
Outputs of similar age
#4,329
of 154,849 outputs
Outputs of similar age from Allergy, Asthma & Clinical Immunology
#1
of 24 outputs
Altmetric has tracked 25,374,647 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 95th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 924 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 13.8. This one has done particularly well, scoring higher than 94% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 154,849 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 97% of its contemporaries.
We're also able to compare this research output to 24 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 95% of its contemporaries.